Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic pitavastatin calcium 2 mg vs LIVALO 2 mg in healthy Thai volunteers (fasting)
TCTR20221222003Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pitavastatin in hypercholesterolemia (2 arms), sponsored by International Bio Service. Primary endpoint: Bioequivalence of generic pitavastatin vs LIVALO. Status: unknown.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20221222003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221222003.